Robotic-assisted transperineal fusion biopsy led to relatively low rates of prostate cancer upgrading and downgrading in a ...
New evidence compares micro-ultrasound and MRI fusion biopsy for detecting clinically significant prostate cancer. Find out ...
GRENOBLE, France and PRINCETON, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”, www.koelis.com), a leader and innovator in MRI-ultrasound fusion guidance for prostate ...
Seven years after the activation of the prostate biopsy service using Fusion technology, one of the most advanced innovations internationally for combating prostate cancer, the 'San Michele' Clinic in ...
Testosterone Therapy for Severe Hypogonadism Improves Sexual Function In patients undergoing confirmatory biopsy for active surveillance, MRI can increase detection of clinically significant tumors ...
Microultrasonography for prostate biopsy detected clinically significant cancer at rates comparable to MRI-guided approaches. Detection rates for clinically insignificant cancers did not differ among ...
TORONTO, Nov. 5, 2019 /PRNewswire-PRWeb/ -- Focal Healthcare, an innovator of image-guided prostate cancer technology, announced it has received CE Mark for its Fusion Bx 2.0 prostate fusion biopsy ...
GRENOBLE, France and PRINCETON, N.J., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”, www.koelis.com), a global leader and innovator in prostate care, announced today the ...
A prostate biopsy checks for prostate cancer by extracting tissue samples. A transperineal biopsy has a lower infection risk than a transrectal biopsy. Biopsy results are usually ready within about ...
The MarketWatch News Department was not involved in the creation of this content. GRENOBLE, France and PRINCETON, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Koelis, SAS ("Koelis" or the "Company", ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results